Table 5

- Comparison of MBL2 genotype distributions of patients due to the resistance to treatment and clinical specifiers.

	No	Yes	OR	95% CI	P-value
Treatment Resist.
Schizophrenia
MBL2	n= ^a(%)	n=26 (%)
AA	66 (71.7)	21 (80.8)	0.604^*	0.206-1.772^*	0.356^*
AB	22 (23.9)	1 (3.8)	7.857^*	1.006-61.363^*	0.023^*
BB	4 (4.4)	4 (14.8)	0.284^&	0.066-1.218^&	0.093^&
Allele
A	154 (84.1)	43 (81.5)
B	30 (15.9)	9 (18.5)	1.074^*	0.474-2.435^*	0.863^*
Bipolar Dis.
MBL2	n=^b(%)	n=24 (%)
AA	51 (67.1)	22 (91.7)	0.185^*	0.040-0.852^*	0.018^*
AB	21 (27.6)	1 (4.2)	8.782^*	1.114-69.197^*	0.016^*
BB	4 (5.3)	1 (4.2)	1.278^&	0.136-12.015^&	1.000^&
Allele
A	123 (80.9)	45 (93.8)
B	29 (19.1)	3 (6.3)	0.283^*	0.082-0.974^*	0.035^*
Atypical Depres./Bipolar Dis.
MBL2	n=^c(%)	n=20 (%)
AA	55 (68.8)	18 (90)	0.244^*	0.053-1.135^*	0.056^*
AB	20 (25)	2 (10)	3.000^&	0.639-14.079^&	0.228^&
BB	5 (6.3)	0 (0)	1.267^&	1.142-1.405^&	0.580^&
Allele
A	130 (81.2)	38 (95)
B	30 (18.8)	2 (5)	0.228^*	0.052-0.998^*	0.034^*

↵^a n= 92,
↵^b n= 76,
↵^c n= 80, Resist-Resistance, OR- odds ratio, CI - confidence interval, Depres - depression,
↵* Pearson chi-square,
↵^& Fisher’s exact test, Dis - disorder